Literature DB >> 2611068

Pharmacokinetics of rectal ketamine in children.

J L Pedraz1, M B Calvo, J M Lanao, C Muriel, J Santos Lamas, A Domínguez-Gil.   

Abstract

We have studied the pharmacokinetics of ketamine administered rectally in a dose of 10 mg kg-1 to five children aged 6-9 yr and mean weight 28.80 (SD 6.55) kg. An acceptable level of anaesthesia was not obtained in any patient. Despite this, the degree of analgesia obtained was good and no child required further administration of analgesics during the postoperative period. Tolerance to the suppositories was excellent. The absorption of ketamine was found to be relatively fast, with a median peak concentration of 160 ng ml-1 (range 96-250 ng ml-1) at 0.75 h (range 0.50-1.00 h) after administration. The plasma concentrations of norketamine were greater than those of the parent drug, with a maximum of 510 ng ml-1 (range 450-810 ng ml-1) at 0.81 h (range 0.50-1.00 h) after administration. The medians of the half-lives of ketamine and norketamine were 3.15 h and 2.56 h, respectively (range 1.57-4.95 h and 1.47-5.30 h, respectively).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2611068     DOI: 10.1093/bja/63.6.671

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

Review 1.  Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia.

Authors:  D A Haas; D G Harper
Journal:  Anesth Prog       Date:  1992

2.  Comparison of the preventive analgesic effect of rectal ketamine and rectal acetaminophen after pediatric tonsillectomy.

Authors:  S Morteza Heidari; S Zahra Mirlohi; S Jalal Hashemi
Journal:  Int J Prev Med       Date:  2012-03

Review 3.  Clinical Uses of Ketamine in Children: A Narrative Review.

Authors:  Anoushka Bali; Ashujot Kaur Dang; Daniel A Gonzalez; Rajeswar Kumar; Saba Asif
Journal:  Cureus       Date:  2022-07-20

Review 4.  Ketamine: 50 Years of Modulating the Mind.

Authors:  Linda Li; Phillip E Vlisides
Journal:  Front Hum Neurosci       Date:  2016-11-29       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.